Piper Jaffray’s Gitkin Delivers Good News about Ophthalmology Stocks

Piper Jaffray managing director Andrew Gitkin, head of West Coast biotech investment banking, delivers good news to attendees of OIS@AAO. Overall public markets are strong, and while ophthalmology stocks have shown greater volatility than other issue the uncertainty has generated stronger returns.